News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,450 Results
Type
Article (2696)
Company Profile (45)
Press Release (37708)
Multimedia
Podcasts (10)
Webinars (2)
Section
Business (14255)
Career Advice (95)
Deals (2123)
Drug Delivery (9)
Drug Development (4230)
Employer Resources (11)
FDA (460)
Job Trends (818)
News (20448)
Policy (1091)
Tag
Academia (147)
Allergies (7)
Alliances (3516)
ALS (7)
Alzheimer's disease (62)
Antibody-drug conjugate (ADC) (28)
Approvals (461)
Artificial intelligence (34)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (504)
BIOSECURE Act (2)
Biosimilars (17)
Biotechnology (29)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (44)
Cancer (330)
Cardiovascular disease (10)
Career advice (82)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (82)
Cervical cancer (2)
Clinical research (3496)
Collaboration (201)
Company closure (2)
Compensation (104)
COVID-19 (197)
CRISPR (11)
C-suite (112)
Cystic fibrosis (7)
Data (420)
Denatured (7)
Depression (11)
Diabetes (17)
Diagnostics (494)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (2)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (42)
Earnings (4512)
Editorial (5)
Employer branding (1)
Employer resources (9)
Events (6446)
Executive appointments (134)
FDA (605)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (168)
Gene editing (32)
Generative AI (2)
Gene therapy (57)
GLP-1 (66)
Government (163)
Guidances (25)
Healthcare (714)
HIV (1)
Huntington's disease (6)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (210)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1009)
IRA (7)
Job creations (301)
Job search strategy (72)
JPM (5)
Kidney cancer (6)
Labor market (11)
Layoffs (52)
Leadership (3)
Legal (221)
Liver cancer (7)
Longevity (1)
Lung cancer (30)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (316)
Medtech (317)
Mergers & acquisitions (1229)
Metabolic disorders (74)
Multiple sclerosis (22)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (168)
NextGen: Class of 2026 (363)
Non-profit (159)
Now hiring (11)
Obesity (34)
Opinion (18)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (22)
Parkinson's disease (12)
Partnered (4)
Patents (53)
Patient recruitment (25)
Peanut (1)
People (5891)
Pharmaceutical (5)
Phase 1 (1482)
Phase 2 (1719)
Phase 3 (960)
Pipeline (391)
Policy (16)
Postmarket research (34)
Preclinical (643)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (64)
Real estate (426)
Recruiting (5)
Regulatory (940)
Reports (7)
Research institute (153)
Resumes & cover letters (18)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (18)
Series A (46)
Series B (20)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (498)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (53)
Venture capital (16)
Weight loss (23)
Women's health (10)
Worklife (1)
Date
Today (2)
Last 7 days (41)
Last 30 days (178)
Last 365 days (2427)
2026 (215)
2025 (2449)
2024 (2636)
2023 (2873)
2022 (3788)
2021 (4095)
2020 (3533)
2019 (2091)
2018 (1573)
2017 (1810)
2016 (1636)
2015 (1874)
2014 (1382)
2013 (1193)
2012 (1403)
2011 (1333)
2010 (1183)
Location
Africa (54)
Alabama (3)
Arizona (18)
Asia (1959)
Australia (317)
California (1604)
Canada (245)
China (80)
Colorado (54)
Connecticut (16)
Delaware (5)
Europe (4051)
Florida (64)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (49)
Massachusetts (570)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (133)
New York (80)
North Carolina (138)
Northern California (783)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (1)
Rhode Island (2)
South America (49)
South Carolina (1)
Southern California (653)
Tennessee (4)
Texas (152)
United States (3215)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,450 Results for "parse biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis
January 23, 2026
·
2 min read
Press Releases
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
January 20, 2026
·
3 min read
Press Releases
Parse Biosciences Launches Evercode Whole Blood Fixation
December 4, 2025
·
2 min read
Press Releases
Parse Biosciences and Codebreaker Labs Partner to Apply Whole Transcriptome Single Cell Profiling and Causal Genomics at Scale
December 22, 2025
·
3 min read
Press Releases
Tempus Joins Parse Biosciences’ Certified Service Provider Network
October 9, 2025
·
2 min read
Press Releases
Parse Biosciences Announces FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis
November 19, 2025
·
2 min read
Press Releases
Tahoe Therapeutics Selects Parse Biosciences’ GigaLab to Generate 300 Million Single Cell Profiles for Large-Scale Perturbation Atlas
December 12, 2025
·
4 min read
Press Releases
QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions
November 4, 2025
·
8 min read
Press Releases
Parse Biosciences Expands Global Access by Certifying Single Cell Discoveries as a Service Provider
October 1, 2025
·
2 min read
Press Releases
Stealth Third Rock Ventures Backed Company Selects Parse Biosciences GigaLab to Build Largest TCR Atlas for Common Autoimmune Disease
November 13, 2025
·
2 min read
1 of 4,045
Next
